Hammes HP - Search Results

1

The functional role of blood platelet components in angiogenesis.

Rhee JS, Black M, Schubert U, Fischer S, Morgenstern E, Hammes HP, Preissner KT. Rhee JS, et al. Among authors: hammes hp. Thromb Haemost. 2004 Aug;92(2):394-402. doi: 10.1160/TH03-04-0213. Thromb Haemost. 2004. PMID: 15269837

2

Tenilsetam prevents early diabetic retinopathy without correcting pericyte loss.

Hoffmann J, Alt A, Lin J, Lochnit G, Schubert U, Schleicher E, Chavakis T, Brownlee M, Van der Woude FJ, Preissner KT, Hammes HP. Hoffmann J, et al. Among authors: hammes hp. Thromb Haemost. 2006 Apr;95(4):689-95. Thromb Haemost. 2006. PMID: 16601840

3

Regulation of neovascularization by human neutrophil peptides (alpha-defensins): a link between inflammation and angiogenesis.

Chavakis T, Cines DB, Rhee JS, Liang OD, Schubert U, Hammes HP, Higazi AA, Nawroth PP, Preissner KT, Bdeir K. Chavakis T, et al. Among authors: hammes hp. FASEB J. 2004 Aug;18(11):1306-8. doi: 10.1096/fj.03-1009fje. Epub 2004 Jun 18. FASEB J. 2004. PMID: 15208269

4

Angiogenic capacity of endothelial cells in islets of Langerhans.

Linn T, Schneider K, Hammes HP, Preissner KT, Brandhorst H, Morgenstern E, Kiefer F, Bretzel RG. Linn T, et al. Among authors: hammes hp. FASEB J. 2003 May;17(8):881-3. doi: 10.1096/fj.02-0615fje. Epub 2003 Mar 28. FASEB J. 2003. PMID: 12670881

5

Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization.

Hammes HP, Brownlee M, Jonczyk A, Sutter A, Preissner KT. Hammes HP, et al. Nat Med. 1996 May;2(5):529-33. doi: 10.1038/nm0596-529. Nat Med. 1996. PMID: 8616710

6

Topical application of integrin antagonists inhibits proliferative retinopathy.

Riecke B, Chavakis E, Bretzel RG, Linn T, Preissner KT, Brownlee M, Hammes HP. Riecke B, et al. Among authors: hammes hp. Horm Metab Res. 2001 May;33(5):307-11. doi: 10.1055/s-2001-15279. Horm Metab Res. 2001. PMID: 11440278 Clinical Trial.

7

Modification of vitronectin by advanced glycation alters functional properties in vitro and in the diabetic retina.

Hammes HP, Weiss A, Hess S, Araki N, Horiuchi S, Brownlee M, Preissner KT. Hammes HP, et al. Lab Invest. 1996 Sep;75(3):325-38. Lab Invest. 1996. PMID: 8804356

8

Integrin chatter and vascular function in diabetic retinopathy.

Preissner KT, Kanse SM, Hammes HP. Preissner KT, et al. Among authors: hammes hp. Horm Metab Res. 1997 Dec;29(12):643-5. doi: 10.1055/s-2007-979118. Horm Metab Res. 1997. PMID: 9497904 Review.

9

Hyperglycemia impairs proteasome function by methylglyoxal.

Queisser MA, Yao D, Geisler S, Hammes HP, Lochnit G, Schleicher ED, Brownlee M, Preissner KT. Queisser MA, et al. Among authors: hammes hp. Diabetes. 2010 Mar;59(3):670-8. doi: 10.2337/db08-1565. Epub 2009 Dec 15. Diabetes. 2010. PMID: 20009088 Free PMC article.

10

Inhibition of pathologic retinal neovascularization by alpha-defensins.

Economopoulou M, Bdeir K, Cines DB, Fogt F, Bdeir Y, Lubkowski J, Lu W, Preissner KT, Hammes HP, Chavakis T. Economopoulou M, et al. Among authors: hammes hp. Blood. 2005 Dec 1;106(12):3831-8. doi: 10.1182/blood-2005-03-0889. Epub 2005 Aug 25. Blood. 2005. PMID: 16123222 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

231 results

Search Page